AU2002338344A1 - Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis - Google Patents

Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis

Info

Publication number
AU2002338344A1
AU2002338344A1 AU2002338344A AU2002338344A AU2002338344A1 AU 2002338344 A1 AU2002338344 A1 AU 2002338344A1 AU 2002338344 A AU2002338344 A AU 2002338344A AU 2002338344 A AU2002338344 A AU 2002338344A AU 2002338344 A1 AU2002338344 A1 AU 2002338344A1
Authority
AU
Australia
Prior art keywords
trifluoromethylphenyl
cyano
amide
hydroxy
multiple sclerosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002338344A
Inventor
Joseph Wettstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of AU2002338344A1 publication Critical patent/AU2002338344A1/en
Abandoned legal-status Critical Current

Links

AU2002338344A 2001-04-05 2002-04-04 Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis Abandoned AU2002338344A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60/281,685 2001-04-05
GB0123571.2 2001-10-02

Publications (1)

Publication Number Publication Date
AU2002338344A1 true AU2002338344A1 (en) 2002-10-21

Family

ID=

Similar Documents

Publication Publication Date Title
SI1381356T1 (en) Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
GB0123571D0 (en) Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
AU2002354248A1 (en) Positive resist composition and method of forming resist pattern from the same
AU2002354273A1 (en) Positive resist composition and method of forming resist pattern
IL178864A0 (en) 3'-prodrugs of 2'-deoxy-??-l-nucleosides
PL373301A1 (en) Phosphodiesterase 4 inhibitors
HK1072001A1 (en) Parenteral composition of paracetamol
GB0121155D0 (en) Treatment of substrates
AU2002354259A1 (en) Positive resist composition and method of forming resist pattern
IL159538A0 (en) 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors
AU2002257229A1 (en) Compositions comprising d-chiro inositol and sulfonylureas and methods of treatment thereof
IL163926A0 (en) Crystal structure of phosphodiesterase 5 and use thereof
IL152996A0 (en) Novel interferon for the treatment of multiple sclerosis
HK1066022A1 (en) Use of 1,1,1,3,3-pentafluorobutan
AU2002246926A1 (en) 12-hydroxy-eicosatrienoic acid analogs and methods of use thereof
AU2002338344A1 (en) Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
EP1364653A4 (en) Casoase 3 inhibitors
GB0114231D0 (en) Treatment of multiple sclerosis
AU2002357159A8 (en) Manufacture of trialkylaluminum compounds and alpha-alcohols
GB0118670D0 (en) Distribution of information
AU2002251543A1 (en) Novel atisane compound and use thereof
AP2007003992A0 (en) 3'-Prodrugs of 2'-deoxy-beta-l-nucleosides
AUPR589801A0 (en) Modulation of physiological processes and agents useful for same
AU2002316724A1 (en) Ophthalmic use of 5 fluorourcil
AU2002233669A1 (en) Casoase 3 inhibitors